Publication|Articles|August 21, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
Pharmaceutical Executive: August 2025 Interactive Digital Edition
View the Pharmaceutical Executive August 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
5 months ago
The CAR-T Climb5 months ago
2025 Emerging Pharma Leaders5 months ago
An RNA-Guided Path5 months ago
Acceleration and Ambition5 months ago
Driving Disruption in Delivery5 months ago
Building Promise from Precision5 months ago
Determined Problem-Solver5 months ago
How to Get Product Iteration Right in HealthcareNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
3
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5
